SBDS and myelodysplastic syndrome: A recent genomic analysis of 1514 patients with MDS who underwent a stem cell transplant showed that 4% of the young adult patients had undiagnosed compound heterozygous mutations in SBDS, suggesting that SDS prevalence among MDS/AML patients may be underestimated [7].